Osteoporosis Articles

Anabolics

The role of osteoanabolic agents in the management of patients with osteoporosis.

McClung MR, Rothman MS, Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL.

Postgrad Med. 2022 Aug;134(6):541-551. doi: 10.1080/00325481.2022.2069582. Epub 2022 May 30.

PMID: 35635798 Review.

Bisphosphonates

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.

Can Fam Physician. 2014 Apr;60(4):324-33.

PMID: 24733321 Free PMC article. Review.

Denosumab

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review.

Kendler DL, Cosman F, Stad RK, Ferrari S.

Adv Ther. 2022 Jan;39(1):58-74. doi: 10.1007/s12325-021-01936-y. Epub 2021 Nov 11.

PMID: 34762286 Free PMC article. Review.

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.

Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B.

J Clin Endocrinol Metab. 2020 Oct 26:dgaa756. doi: 10.1210/clinem/dgaa756. Online ahead of print.

PMID: 33103722

Fracture Liaison Service

To Break or Not to Break (Again): Is That the Question?

Kherani RB, Singh S. CRAJ. 2022;32(3):12

* Posted with permission from publisher

Vertebral fractures

Vertebral Fractures: Clinical Importance and Management.

Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, Yuen CK, Lewiecki EM.

Am J Med. 2016 Feb;129(2):221.e1-10. doi: 10.1016/j.amjmed.2015.09.020. Epub 2015 Oct 30.

PMID: 26524708 Review.